Zukoski Outpatient

Zukoski Outpatient is an addiction-treatment facility located in Maitland, FL. The facility's programming is outpatient (Outpatient, Dual Dx), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Zukoski Outpatient

On care levels specifically: Zukoski Outpatient is an outpatient-focused program (Outpatient, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What that means in practice is that matching Zukoski Outpatient to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

On insurance specifically: Zukoski Outpatient operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Clients with co-occurring mental and substance use disorders. If that matches what you or your family member need, great — and worth asking specifically about what the programming looks like day-to-day (how many hours per week of specialty-specific content, who leads it, what credentials they hold).

Before you call

Before admission to Zukoski Outpatient, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Zukoski Outpatient offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.